EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Impact of Socio‐Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B

Clémence Ramier iD, Anders Boyd iD, Colette Smit, Rosan van Zoest, Mark A A Claassen iD, Katalin Pogány, Dirk Posthouwer, Theodora E M S de Vries-Sluijs, Patrizia Carrieri, Marc Van der Valk

Liver International · 2025

DOI: 10.1111/liv.70191 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Liver International, 2025. Verfasst von Clémence Ramier und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de L'information Médicale, ISSPAM, Marseille, Fran…. Hauptthemen laut MEDLINE: HIV Infections, Hepatitis B, Chronic, Coinfection, Liver Cirrhosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Little is known about the contribution of sociodemographic and behavioural factors to developing liver disease in individuals with an HIV and chronic hepatitis B virus (HBV) co‐infection. We aimed to quantify the impact of these factors on incident liver disease in individuals with HIV/HBV receiving care in the Netherlands.

Methods

We used data from the Dutch observational ATHENA cohort combined with Statistics Netherlands. We included all hepatitis B surface antigen‐positive individuals with HIV in care from 2008–2022. Severe liver disease (i.e., significant fibrosis (≥F2), cirrhosis, hepatocellular carcinoma, liver transplantation) was defined by physician diagnosis or a transient elastography result > 7 kPa. Determinants of incident liver disease were assessed using Cox proportional hazard models.

Results

In the 1319 individuals included (12,277 person‐years (PY); 93.3% HIV‐RNA < 200 copies/ml), the incidence rate of severe liver disease was 0.59 per 100 PY [95% confidence interval (CI) = 0.47–0.75]. After adjustment for age and time since HBV diagnosis, tobacco smoking, HCV coinfection and body mass index > 25 kg/m 2 increased the risk of liver disease [adjusted hazards ratio (aHR) = 2.33, 95% CI = 1.38–3.94; aHR = 4.00, 95% CI = 2.18–7.33, aHR = 1.75, 95% CI = 1.05–2.92, respectively]. Conversely, men who have sex with men (vs. other transmission routes, aHR = 0.54, 95% CI = 0.32–0.90), and individuals living in an urbanised municipality (aHR = 0.50, 95% CI = 0.30–0.85) had a reduced risk of liver disease.

Conclusions

Liver disease progression in people living with HIV/HBV appears to be linked to psychosocial/behavioural factors. More effective screening/management of coinfection and metabolic syndrome, as well as strategies for smoking cessation, should be included in clinical follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHepatitis B, ChronicCoinfectionLiver CirrhosisHumansMaleFemaleNetherlandsMiddle AgedDisease ProgressionAdultRisk FactorsIncidenceSocioeconomic FactorsLiver NeoplasmsProportional Hazards ModelsCarcinoma, Hepatocellular

Stichwörter der Autor:innen

HIVbehaviourhepatitisliver diseasesocioeconomyurbanisation

Autor:innen und Institutionen

  • Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Économiques & Sociales de la Santé & Traitement de L'information Médicale, ISSPAM, Marseille, France.
  • Amsterdam UMC, Location University of Amsterdam, Amsterdam Institute for Immunology & Infectious Diseases, Infectious Diseases Program, Amsterdam, the Netherlands.
  • Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.
  • Stichting Hiv Monitoring, Amsterdam, the Netherlands.
  • Amsterdam Health and Technology Institute, Amsterdam, the Netherlands.
  • Rijnstate Hospital, Department of Internal Medicine, Infectious Diseases Unit, Arnhem, the Netherlands.

ORCID-Profile: Clémence Ramier, Anders Boyd, Mark A A Claassen

Zitieren

APA

Ramier, C., Boyd, A., Smit, C., van Zoest, R., Claassen, M. A. A., Pogány, K., Posthouwer, D., de Vries-Sluijs, T. E. M. S., Carrieri, P., & Van der Valk, M. (2025). Impact of Socio‐Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B. Liver International. https://doi.org/10.1111/liv.70191

Vancouver

Ramier C, Boyd A, Smit C, van Zoest R, Claassen MAA, Pogány K, et al. Impact of Socio‐Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B. Liver International. 2025. doi:10.1111/liv.70191

BibTeX
@article{Ramier2025,
  author = {Ramier, Clémence and Boyd, Anders and Smit, Colette and van Zoest, Rosan and Claassen, Mark A A and Pogány, Katalin and Posthouwer, Dirk and de Vries-Sluijs, Theodora E M S and Carrieri, Patrizia and Van der Valk, Marc},
  title = {Impact of Socio‐Economic, Behavioural and Clinical Factors on Liver Disease Progression in Individuals With HIV and Hepatitis B},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.70191}
}
Kostenlos starten →